
0:000:00
<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1743909/open_sms">Send us a text</a></p><p>Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. John Fralick. This week, he discusses a recently published trial comparing rituximab with conventional strategy for the induction of remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Here we go!</p><ol><li><a href='https://www.acpjournals.org/doi/10.7326/ANNALS-24-03947'>Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis: A Randomized Controlled Trial</a> (0:00 – 5:40).</li></ol><p>The Good Stuff (5:41 – 6:31):</p><ul><li>The I'm Pharmacy podcast, now featured on Medicine Pods: <a href='https://medicinepods.com/im-pharmacy/'>https://medicinepods.com/im-pharmacy/</a>.</li></ul><p>Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods</p>